ARIPIPRAZOLE-ZP aripiprazole 30mg tablet blister pack

국가: 오스트레일리아

언어: 영어

출처: Department of Health (Therapeutic Goods Administration)

지금 구매하세요

공공 평가 보고서 공공 평가 보고서 (PAR)
26-11-2017

유효 성분:

aripiprazole, Quantity: 30 mg

제공처:

Medis Pharma Pty Ltd

INN (International Name):

aripiprazole

약제 형태:

Tablet, uncoated

구성:

Excipient Ingredients: microcrystalline cellulose; lactose monohydrate; maize starch; magnesium stearate; hyprolose

관리 경로:

Oral

패키지 단위:

30

처방전 유형:

(S4) Prescription Only Medicine

치료 징후:

Aripiprazole is indicated for the treatment of schizophrenia including maintenance of clinical improvement during continuation therapy.,Acute treatment of manic or mixed episodes associated with Bipolar I Disorder in adults as monotherapy and in combination with lithium or valproate;,Maintenance treatment of manic or mixed episodes in Bipolar I Disorder in adults as monotherapy.

제품 요약:

Visual Identification: 9mm, round, biconvex, white uncoated tablets with 30 debossed on one side and ZL on the other side; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius

승인 상태:

Licence status A

승인 날짜:

2014-10-29